If you would like to have your event listed on the BayBio community calendar, send us an e-mail: info@baybio.org. Please make sure to include date, name and location of your event, a short description, cost and how to register. The BayBio Community Calendar is updated every Tuesday. To ensure proper exposure, we recommend sending your information to us a minimum two weeks prior to your event. All postings are subject to BayBio approval. Please note: the BayBio Community Calendar is updated once per week, every Tuesday afternoon.

To follow other Northern California life sciences community happenings and events, click the logos below to become a fan of the BayBio Facebook page or to follow us on Twitter.

 

September Events

September 2010: Bioscience 1: Overview of Microscopy
Biological Sciences 1 is an "Introduction to microscopy" course that includes hands-on training on our new digital imaging systems. You will get a broad introduction to a variety of microscopy techniques and careers, plus lab experience with digital fluorescence microscopy. This is a great way to get a taste of what awaits you in the program and to figure out if this is the career for you! In Oakland. Detailed Information

September 1: BioE2E Licensing strategies - views from the trenches!
So you have assets that are ready to be monetized; how can you get the best deal...? The panel will use their own vast experiences to discuss the considerations and opportunities for licensing compounds and platform technologies. Topics to be discussed include how deal terms are driven by the nature of the asset being licensed; how the decision on when, and what assets to license can impact your overall business model; how do you chose the right partner and how can the partnership be maintained and enhanced once the deal is signed? In Palo Alto. Detailed Information

September 1, 2010: Agile Management: A New Management Paradigm
Agile Management is a framework of values, principles, and practices that allows managers to work more successfully. Come hear from a panel of senior managers how Agile is becoming a vital new management paradigm. In San Francisco. Detailed Information

September 1: Principles of Molecular Biology
Focus on DNA structure and replication, RNA and protein synthesis, and the genetic code in the first in a two-semester sequence. Gain an understanding of the fundamental concepts and complexities of aspects of molecular biology, both structures and processes, common to most organisms. You also learn to critically evaluate current scientific literature, learn about important molecular biology tools and techniques, and investigate the experimental basis of molecular biology. Detailed Information

September 1: Stem Cell Biology, Research and Discovery
Review the science and current research topics in the field of human embryonic stem cells, and learn how they are being applied to regenerative medicine. Examine the basic elements of human embryonic stem cell biology and development as well as the derivation, cultivation, and development of technologies in the field. This course is associated with three other core courses that focus in detail on the ethical, business, and process development issues surrounding research, development, and commercialization of therapies and products from human embryonic stem cells. Detailed Information

September 2: Stanford Mass Spect Users
Workshops and symposium for users of Stanford mass spec resources as well as those interested in finding out more about the technology and its applications. The Mass Spec Users’ Meeting is an annual opportunity for Stanford and community scientists to meet, mingle, and learn about mass spec related research and resources at Stanford. Meals and refreshments will be provided for registered attendees. The meeting will be followed by a reception and prize raffle at 4 pm. Open to the public.At Stanford University. Detailed Information

September 2: Startup Strategies: How to Maximize the Value of Your BioPharma IP
Maximizing the value of your BioPharma IP begins with being strategic about your end-game. You want to pay less and achieve more from your innovations and investments, and to minimize the risk of losing ownership or control over what's rightfully yours. The smart approach? Develop an IP strategy that considers your full potential for licensing, investment, merger and acquisition while delivering full protection for your patentable assets. Join startup strategists from Townsend and Townsend and Crew, Aquilo Partners and SageSpring Partners to learn how companies today are managing to get more value for their dollar by developing integrated IP and business strategies that minimize their risks and maximize their investment value. Our programs are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. In San Francisco. Detailed Information

September 2: San Jose Biocenter | Startup Strategies: How to Maximize the Value of Your BioPharma IP
Maximizing the value of your BioPharma IP begins with being strategic about your end-game. You want to pay less and achieve more from your innovations and investments, and to minimize the risk of losing ownership or control over what’s rightfully yours. The smart approach? Develop an IP strategy that considers your full potential for licensing, investment, merger and acquisition while delivering full protection for your patentable assets. Join startup strategists from Townsend and Townsend and Crew, Aquilo Partners and SageSpring Partners to learn how companies today are managing to get more value for their dollar by developing integrated IP and business strategies that minimize their risks and maximize their investment value. In San Francisco. Detailed Information

September 3: San Jose BioCenter presents | Meet with...Merck
In this session, Licensing Directors from Merck & Co., Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Merck team. Finally, each pre-approved attendee* will be granted a private meeting with Dr. James M. Schaeffer - the Executive Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. - or Dr. Yael Weiss - the Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. In San Jose. Detailed Information

September 7: Biotech and the Global Marketplace: Opportunities in India
India's biotechnology sector is estimated to be $10 billion by 2015. The industry is expected to grow from present $2.51 billion (FY 2008-2009) to $5 billion by 2011. The Indian biotechnology sector, is one of the fastest growing knowledge-based sectors, and is expected to play a key role in shaping India's rapidly developing economy. U.S. Department of Commerce, U.S. Commercial Service Biotech Specialist, Sathya Prabha from the U.S. Consulate in Hyderabad, India, will be presenting on opportunities in India and the biotech sector, as well as, U.S. Commercial Service assistance on identifying export and partnership opportunities in India. Come learn about India’s biotech market and latest trends, as well as, U.S. government resources that can help you find partners and tap into the biotech market in India. In Santa Clara. Detailed Information

September 7: Bio2Device Group | The Trials and Tribulations of Combination Product Development
There are many good reasons to develop pharmaceutical/medical device combination products: improved safety and efficacy; targeted delivery; patent extension; or breathing new life into old drugs or devices, to name a few. However, developing such products can be troublesome. There are many technical and regulatory hurdles that must be overcome. This talk will address some of the unique problems associated with developing drug/device combination products, as well as give some pointers on how best to deal with these problems. In Sunnyvale. Detailed Information

September 7: Developmental Biology
How does a single cell, the fertilized egg, give rise to a complex organism that contains many different cell types, tissues, and organs? How do the organs develop to the right size in the right place to give rise to a functional animal? Developmental biology seeks to answer these questions by studying cellular behavior and molecular pathways that control patterning in the developing embryo. You study different model organisms in this course, with an emphasis on vertebrates, and cover the most recent advances and techniques in developmental biology. Detailed Information

September 7: Neuroscience
Get an overview of the fundamental principles of the organization, function, and development of the human nervous system including neural development and diseases of the nervous system. You examine experimental approaches from anatomy to molecular biology and critically evaluate papers from the primary scientific literature. Ultimately, you can use
this course as a foundation for advanced study in the neurosciences. Detailed Information

September 7: Medical Virology
Learn about Marburg, West Nile, HIV, flu, and most other viruses of current medical importance. You study the entire process of virus-mediated disease by first building a foundation in the molecular understanding of the virus infection cycle and then focusing on public health monitoring, disease processes, and treatments. This course is recommended for people with an interest in the medical, academic, or industrial fields of public health and/or molecular biology of viruses.Detailed Information

September 8: Association of Women in Science - SF Chapter | Managing Mood, Maximizing Opportunities: An Introduction to the Power and Possibilities of Moods
Moods can be pervasive and subtle; they can significantly impact our identity and how we interact with others. Exceptional leaders take responsibility for their own moods, recognize the moods of others, and know the power of leading a team in a positive mood. Attend this dynamic, interactive presentation and learn more about the phenomena of moods, the difference between moods and emotions, and how moods can influence our possibilities for the future. In South San Francisco. Detailed Information

September 9: Medical Device Trials 2010-What We Need to Know About Audits and Inspections
This is the year FDA is focusing on streamlining and improvements in device clinical trials. What’s new and important? What can we learn from recent device warning letters? Are you prepared for an audit or inspection? When does preparation begin and how to plan? Our speaker was invited to return this year to share her expertise after a sellout and well received presentation last year. Bring questions! This Educational Event presented by NCC ACRP. Contact hours available. Registration cost: free-$15 includes networking buffet. In Mountain View. Detailed Information

September 9: Starting a BioPharma Company: How the Pieces Fit Together
Michael O'Donnell, J.D., will review the key aspects of founding a biopharmaceutical company, including formation, technology in-licensing, financing, and corporate partnering strategy. In San Francisco. Detailed Information

September 9: VC Spotlight | Diabetes Diagnostics, Monitoring and Treatment
The prevalence of diabetes continues to grow, with nearly 8 percent of the U.S. population, or 23.6 million children and adults, who are living with the disease. According to the American Diabetes Association, nearly one third of the total economic cost of the disease – $174 billion – accounts for chronic diabetes-related complications. The increased percentage of people living with diabetes has led many Northern California life science companies to focus their development efforts on innovative treatments for the disease. This large and growing size of the patient population was not lost of the Northern California venture community with a number of Venture Capitalists and Angels investing heavily in diabetes diagnostics, monitoring and care. In a reverse pitch format a panel of investors will discuss their current interests, at what stage they are looking to invest, target markets and opportunities, therapies and technologies. Q&A and networking will provide an opportunity to better understand and form a successful relationship with investors. In Menlo Park. Detailed Information

September 9: Executive Reception with Jeremy Leffler Chief Operating Officer, BayBio
Attend an executive reception welcoming the newest addition to the BayBio team - Chief Operating Officer, Jeremy Leffler. No boring speeches, no official program - just an opportunity to connect for BayBio Board and BayBio Partners over a glass of wine and Hors d'oeuvres in a relaxed atmosphere. In San Francisco. Detailed Information

September 10: Application Deadline for Astia's Doing It Right
Apply to become a member of Astia's Doing It Right Program Silicon Valley 2010. This is a "venture accelerator" for women-led life science companies. Application deadline is September 10th. Detailed Information

September 11, 2010: Agile Management for Project Managers
Gain hands-on experience with basic Agile Management tools and techniques and learn what it means to be an Agile project manager. Learn about the Agile project life cycle and how Agile teams work so you can apply the knowledge to your projects. In San Francisco. Detailed Information

September 11: Mammalian Systemic Physiology
Study fundamental concepts of mammalian physiology (primarily human), including neural, muscular, cardiovascular, respiratory, renal, endocrine, digestive, and reproductive physiology. Explore in detail homeostasis, molecular and cellular physiology, and the functions of tissues, organs and organ systems. At the end of the course, you better understand current
topics of experimental research and grasp key concepts of experimental research. Biology majors, pre-medical, pre-health students, and those looking for a career change or to refresh their physiological knowledge can benefit greatly from this experience. Detailed Information

September 11: Pharmacoeconomics
Get an introduction to the basic principles of pharmacoeconomics and outcomes research at the level of the national health economy, the biopharma company, and the decisions affecting individual patients and physicians. Study topics such as the structure of the biopharma industry; costs related to drug development, particularly in clinical trials; and cost and decision
analyses related to drug and other medical treatments. You cover these topics with an industrial and an academic focus; you also learn qualitative theory as well as quantitative analysis and applications. Detailed Information

September 11: The Manufacturing Plant-Design Through Commissioning
Understand the role of supply chain and manufacturing professionals in the design and construction of manufacturing facilities in a regulated environment. Gain an understanding and working knowledge of the process, from design to commissioning a cGMP manufacturing facility. Study the interactions and relationships within an organization to design and successfully commission a manufacturing facility. Detailed Information

September 11: Good Manufacturing Practices (GMP): Quality Assurance (QA) in Practice
Understand the role of quality assurance (QA) in a functional GMP plant that is making materials for clinical trials and commercial operations, including roles, responsibilities, and reporting relationships. Using case studies, master the plant's various systems and how they interface with the rest of the operation, and understand the various regulations and how they must be implemented. Detailed Information

September 12: Health Careers Seminar II
This second of a two-course required sequence prepares you for the comprehensive application process to health career professional programs. You review healthcare professional programs and further clarify your interest in healthcare careers, admission requirements, length of study, and workforce issues. You plan your approach for the written application form.
You learn to write personal statements and practice interview questions. You also learn strategies to finance your healthcare education. Your classroom experience includes lectures, in-class interactive presentations, case studies, and opportunities for private and semi-private meetings with the instructors. Detailed Information

September 13-14 |The Future of Bio-Based Chemicals – Inception to Marketplace
Join your colleagues at GTCbio’s The Future of Bio-Based Chemicals—Inception to Marketplace Conference, for two days of essential, timely, and informative presentations. The event will address new technologies, investment trends, and updates on exciting developments, such as the Algae and Woody-Mass feedstocks. In addition, discussions on future synergy among the bio-sectors, bio-refinery partnerships with petrol-refineries and ethanol plants, and updates on government policy will be included. Don’t miss this opportunity to share ideas, develop partnerships, and network with key start-ups, traditional oil-based companies, feedstock suppliers and investors passionate about continued growth and business development in the bio-based chemical industry. BayBio members receive 10% discount when registered by September 1. Detailed Information & Registration

September 13: Post-Baccalaureate Health Professions Program Information Session
Find out about this specially designed program that provides academic preparation in the sciences and advising to enhance your application for admission to medical, dental, or veterinary school, or to advanced degree programs in the health professions. For more information about the Health Professions program, visit extension.berkeley.edu/spos/premed.html. Detailed Information

September 14: Planning for Study Success: Better Safety, Better Design and Better Enrollment - Dinner Event
Successful outcomes in clinical trails is a never-ending challenge in today's climate. Key obstacles include identifying the right sites, protocol feasibility and proactively managing safety. Join your colleagues and discover ways overcome these challenges with experts in the field. During the presentation you will discover: ways to find the best clinical trial investigators, how to assess protocol feasibility with insurance claims data, how to use adaptive clinical trial design and overcoming operational issues, anticipating and recognizing adverse events and tools to avoid premature discontinuation of a drug. For more information and to RSVP by Sept. 8 for this hosted dinner event at MacArthur Park in Palo Alto contact: discover@i3global.com

September 14: BioBriefing: Industry Knowledge for the Non-Scientist
Become more instrumental in your company's success by understanding the science and technology driving the biotech and pharmaceutical industries. Be more strategic in your relationship-building by knowing who the industry players are and how they interact. Learn from credentialed BioTech Primer instructors that have the skill and experience to teach executives with a wide variety of non-science backgrounds in an engaging environment. In San Jose. Detailed Information

September 14: The Life Sciences VC Connection
The Life Science VC Connection programs through VC Taskforce offer an opportunity for entrepreneurs seeking start up funding to pitch in front of a distinguished panel of investors. VC Taskforce and Morgan, Lewis & Bockius, LLP have partnered to bring to you a scintillating program series to bring entrepreneurs and VCs together in the life science fields. The evening will be exciting and a terrific learning experience for all entrepreneurs. Entrepreneurs learn what VCs are looking for in a pitch presentation. In Palo Alto. Detailed Information

September 14: Networking Dinner with BioScience Forum
French Bio Bay comes together again for its next event on Tuesday 14 September starting at 7 PM. The event will take place at the Delancey Street Restaurant in San Francisco, CA, USA, where Joseph A. Carlino, Ph.D., President of The BioScience Forum (BioSF) will introduce his organization. In San Francisco. Detailed Information

September 14: Identify & Mitigate Risks to Avoid Late-Stage Attrition Register to attend today!
Why do so many products fail so late in the development process? R&D costs are soaring, regulatory requirements are rising, and comparative effectiveness hurdles loom. Now more than ever, flawed product advancement decisions can take a huge toll on biopharmaceutical companies. The risk of failure should decrease dramatically as drugs advance from Phase I to Phase III trials, yet the evidence shows otherwise: high-profile, late-stage product failures remain a core feature of the industry’s news cycle. Deloitte Recap data show 30% of products fail in Phase III pivotal trials and 11% fail even later, after a licensure submission has been made. What can the data tell us about why this keeps happening and how to identify and mitigate the risks. Can’t attend live? Register to receive the recorded webinar and accompanying slides. Webinar. Detailed Information

September 14: Bio2Device Group | What Drives and Motivates VCs
Speaker: Maria C. Walker, Senior Director, Venture Capital Practice, KPMG. Detailed Information & Registration

September 14: GLG Webcast | Personalized Medicine
Gryorgy Abel, MD, PHD, is the Medical Director of Clinical Immunology and Molecular Diagnostic Laboratories at the Lahey Clinic in Massachusetts. GLG will be hosting a Personalized Medicine webcast where Mr. Abel will discuss the most recent and important technological and testing trends. Other topics include readiness of healthcare providers to embrace personalized medicine and the evidence-based medicine supporting (or questioning) the personalized medicine approach. Detailed Information

September 15: The Future of Clinical Trials
The pharmaceutical industry is in the midst of perhaps the largest shift since the development of Medicaid & Medicare some forty-five years ago. Competition is fierce, global and strong. Many multinational drug companies are now partnering with generics, exploring emerging markets more aggressively for future revenue and struggling with current industry regulations. As pharmaceutical pipelines continue to lag, pressure is now being put on R&D - once an "untouchable" part of the business cycle. The entire supply chain needs efficiencies - and soon. In San Francisco. Detailed Information

September 15: BioScience Forum Presents Gideon Bollag, Ph.D. Senior Vice President of Research Plexxikon
Kinase inhibitors are gaining prominence in the fight to treat a variety of human cancers, and different approaches targeting two kinase pathways will be discussed: RAF and FMS. The identification of RAF kinases (A-, B-, and C-RAF) as important effectors of the RAS oncogene subsequently led to drug discovery efforts to identify potent inhibitors of RAF kinase. One such discovery project led to the identification of sorafenib, a potent inhibitor of C-RAF kinase. Despite the successful development of sorafenib as a therapeutic option for patients with metastatic kidney and liver cancers, an understanding of the mechanistic role of C-RAF inhibition remains enigmatic even ten years since its initial discovery. Dr. Bollag has served as senior vice president of research at Plexxikon since June 2008, and has more than 20 years of biotechnology drug discovery experience. He previously served as vice president of discovery biology since 2004 and joined Plexxikon as senior director of drug discovery in 2002. In Milbrae. Detailed Information

September 15-16: California Industrial Biotech Conference
BIOCOM and BayBio are creating a day and a half conference that will combine the business, research and investment aspects for the industrial biotech community in this unique statewide conference. Through panel discussions, partnering opportunities and ample networking opportunities to extend your relationships. This conference will educate participants on the opportunities and challenges facing industrial biotech companies and ultimately demonstrate why California is a center of innovation in the industrial biotech space. At the Hard Rock Hotel- San Diego, CA. Detailed Information

September 16: Principles of Infectious Diseases and Emerging Infectious Diseases
Improve your understanding of the basic concepts of infectious diseases, dynamics of disease transmission, and the emerging and reemerging infectious diseases from many perspectives. You also focus on host-pathogen relationships and the mechanisms of emergence of new microbial threats. From an initial review of some common terms, you progress into detailed discussions on how pathogens establish themselves within a host to sustain an infection. Detailed Information

September 17: Applying the Principles of Project Management in Preclinical Development
Upon successful completion of this course, you should be able to understand, define, apply and execute project management best practices in the earliest stages of pharmaceutical research and development: drug discovery and preclinical development. Master the framework for developing a preclinical plan based on a solid target product profile, and explore ways to gain efficiencies in terms of time budgets and resource usage. Learn through lectures, case studies, problem sets, and class discussion. Practical application of project management fundamentals within the discovery and preclinical environments is emphasized. This course covers the critical elements of the drug development discovery phase before detailing how project management can make the preclinical phase of drug development a lot more efficient. Detailed Information

September 17: MDMA | Medical Technology Executive Forum- Providing Entrepreneurs & Innovators Information for Success
The Medical Device Manufacturers Association (MDMA), the leading voice in Washington, DC for innovative and entrepreneurial medtech companies, is hosting its 3rd annual Medical Technology Executive Forum. This must-attend one day interactive forum will bring together more than 100 CEOs and senior executives to discuss the critical issues that affect product commercialization. Industry experts and government officials will address investment options, FDA reform, reimbursement challenges, protecting IP and much more. In addition, speakers will discuss managing these key elements as a company plans for the successful launch of new products and technologies. BayBio Members recieve a $100 discount. OEM's of a medical technology with sales under $500,000, who register for the Medical Technology Executive Forum on September 17th at the non-member rate of $545, are eligible for a 1 year membership to MDMA. Fist time members only, eligibility subject to verification. In Palo Alto. Detailed Information

September 18: Good Clinical Practices (GCP): Drugs and Biologics Whether you are new to product development and clinical research or currently involved in the field, this course provides a solid ethical and regulatory foundation in understanding Good Clinical Practices (GCP) for clinical research conducted under the U.S. Code of Federal Regulations (CFR) associated guidelines. In addition to discussing FDA audits and inspections in relation to GCP requirements, you cover the requirements for all stages of product development, from concept to FDA approval for marketing to post-marketing activities. Detailed Information

September 18: Clinical Trial Implementation: Site Initiation, Subject Recruitment, Monitoring, and Safety Reporting
Get a thorough look at the role of clinical trial monitors. Review in detail the various aspects of study monitoring, such as data review, safety reporting, and drug accountability. You also study global drug development and subject recruitment and retention, topics that are crucial to meeting study timelines. Detailed Information

September 18: Professional Program in Biopharmaceutical Business
The Professional Program in Biopharmaceutical Business features a comprehensive curriculum that encompasses the specific business needs of the biopharmaceutical industries. Electives draw from other areas within this industry to ensure that professionals from all backgrounds can communicate easily and understand the roles of various functions within disparate business units. Detailed Information

September 18: The Business of Biotechnology
Gain an understanding of the biotechnology industry—what makes it so compelling and what makes it one of the riskiest sectors for investors. Study the career paths of some of the innovative entrepreneurs who created the industry back in the late 1970s. Learn about the risks they took and how the value they generated surpassed even that of dot-com successes. You also get a guided tour of the mysteries of the drug development process and the convoluted funding trail, from venture capital through that all-important initial public offering (IPO). Detailed Information

September 20: Great People Decisions–Why They Matter, Why They Are Difficult, and Tips on How to Master Them
The QB3 Entrepreneurs’ Discussion (QED@QB3) series seeks to inspire, connect, and educate entrepreneurs. The backbone of the program consists of luncheon seminars by leading entrepreneurs, venture capitalists, and industry experts on technical matters necessary to launch a successful bioscience startup. These seminars also provide a great venue for members of the QB3 Garage Network and wider biotech community to meet with entrepreneurial students, staff, and faculty. We also hold special seminars at other times. In San Francisco. Detailed Information

September 21: Green Chemistry in the Pharmaceutical Industry
Hear about greener chemical reactions, environmental footprint reduction benchmarking, legislative action, education, and globalization in this lively talk. In Berkeley. Detailed Information

September 21: Bio2Device Group | Isonostics™ - The Next Generation of Diagnostics
Target Discovery is developing the next generation of clinical diagnostics, offering higher value molecular insights for the diagnosis and management of disease. The company’s initial commercial focus is on the new class of protein isoform biomarker diagnostics (Isonostics™) that better guide therapeutic choices for cancer and lower the overall costs of cancer treatment. The company engages in funded collaborations with partners, for application of its unique isoform-level technologies in other disease areas and in theranostic applications (diagnostic testing to select or disqualify patients for a specific drug therapy). Isonostics refers to diagnostic tests based on protein isoforms. Traditional immunodiagnostic assays report the overall up- or down-regulation of a parent protein family, typically combining all isoforms of that protein into the result (causing loss of specificity and sensitivity). Molecular diagnostics (DNA/RNA level) offer insights into single nucleotide polymorphisms (SNPs) and splice variants, which account for only a small portion of all protein isoforms. Target Discovery's Isonostic assays do capture and quantify expressed mutations (SNPs) and splice variants, but ALSO quantify the much wider variety of post-translational modifications (PTMs) that are not currently differentiated by existing clinical diagnostic products but are typically the critical determinants of disease conditions and treatment optimization. In Sunnyvale. Detailed Information

September 22: The Pharmaceutical Development Process
Pharmaceutical development is a multidisciplinary team effort, requiring constant control of very high costs and resource demands. Get an overview of all disciplines involved in the development of a new pharmaceutical product (drug or biologic) from the discovery stage through nonclinical, manufacturing, and clinical development to marketing approval. Gain an understanding of the role of each discipline, the impact of ever-changing regulations on each discipline, where the roadblocks may occur, and the vocabulary to ask probing questions of team members. Detailed Information

September 23: Opportunities in the Changing World of Healthcare
With healthcare costs skyrocketing, there is more urgent need for more cost-effective methods for delivering care. One class of solutions is focused on early and less expensive interventions using information technology and consumer medical electronics. As a result, there are new and interesting business and professional opportunities at the convergence of life sciences, information technology, engineering and consumer services. This presentation will provide an overview of the current market and some exciting trends and opportunities. In Emeryville. Detailed Information

September 23: BIGs Clean Tech: Green Lifestyle – Business of the Future
More and more venture capitalists are now backing green entrepreneurs who aim to invent green-consumer products and technologies for the mass market consumer. The press talks about the new green car on the roads, the solar panels on business rooftops, and the smart-meter devices in homes. What will come next? Our stellar panel features industry insiders from PricewaterhouseCoopers, Applied Ventures, Venrock, Cooley LLP and more. In Palo Alto. Detailed Information

September 23: San Jose BioCenter | Doing Deals with Big Pharma
From alliance to funding, Big Pharma and established biotech companies are increasingly investing in emerging companies. This Panel brings together executives from these larger companies to identify the type of deals now available to smaller companies, how to secure them, and how to manage them. In Menlo Park. Detailed Information

September 24: Scientific Symposium in Diabetes
Please join Diabetes Center Director Matthias Hebrok, PhD, and Diabetes Center Faculty at our SCIENTIFIC SYMPOSIUM as we celebrate the 10th Anniversary of the establishment of the Diabetes Center at UCSF that united diabetes research, clinical care and education into a comprehensive program for the benefit of those living with diabetes. We are honored that ten outstanding diabetes medical professionals and researchers from UCSF, Harvard Medical School, Harvard School of Public Health, Columbia University School of Medicine, and the San Raffaele Hospital and Scientific Institute, Milan Italy will be making presentations at this day-long symposium, moderated by Director Hebrok. Topics include: Immunology and Type 1 Diabetes; Stem Cells and Regeneration; Obesity and Metabolism; and Clinical Research in Diabetes. Also scheduled to speak are UCSF Chancellor, Susan Desmond-Hellmann, MD, MPH, and Executive Vice Chancellor & Provost, Jeffrey Bluestone, PhD. In San Francisco. Detailed Information

September 25: Biotechnology Business Development
This course provides an understanding of the critical roles of the business development function in commercializing a biotech discovery. With real-world examples, the following key topics are addressed: acquiring a new product, assessing the product's global market potential, financing a product's development or acquisition, building a commercialization team,
continually increasing the company's valuation, marketing and negotiating in- and/or out-licensing deals, protecting intellectual property, and strategies for attaining a product's fullest potential, including collaborations, partnerships, and mergers. Detailed Information

September 27: BioDesign Roundtable | New Directions in US Medical Device Regulation
Speaker: Jeffrey Shuren, MD,JD,Director, FDA Center for Devices and Radiological Health (CDRH). At Stanford University. Detailed Information

September 27: FountainBlue | Medical Device Advances: From Implantables to Surgical Tools, From Diagnostics to Therapeutics
This month, we will highlight successful medical device solutions from implantables to clinical equipment and also cover partnering across academia and industry to advance the industry, and the future of medical device industry in general. In San Jose. Detailed Information

September 27-28: The Burrill Personalized Medicine Meeting
The 6th Annual Burrill Personalized Medicine Meeting is a two-day event, which encompasses detailed discussions on the whole spectrum of personalized medicine – from prediction to prevention – provides attendees with a detailed “window” into the emerging personalized medicine world and challenges and opportunities that this new paradigm presents.This year’s agenda will focus on the impact that broader healthcare reform will have on personalized medicine. The meeting encourages participation, focusing on intimate discussions with small groups of panelists and expert moderators, and encourages participation from the expert audience. In addition, selected top drawer keynote speakers will round out the program. In San Francisco. Detailed Information

September 28: University-Biotech Collaborations: Clearing the Path for Innovation
The QB3 Entrepreneurs’ Discussion (QED@QB3) series seeks to inspire, connect, and educate entrepreneurs. The backbone of the program consists of luncheon seminars by leading entrepreneurs, venture capitalists, and industry experts on technical matters necessary to launch a successful bioscience startup. These seminars also provide a great venue for members of the QB3 Garage Network and wider biotech community to meet with entrepreneurial students, staff, and faculty. We also hold special seminars at other times. In San Francisco. Detailed Information

September 28: Meet with Merck & Co.
Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the “Meet with…” Series, we provide emerging companies with greater access to partnering and/or financing opportunities. In this session, Licensing Directors from Merck & Co., Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Merck team. In San Jose. Detailed Information

September 28: CIRM / Regenerative Medicine Consortium Webinar: Preclinical Animal Model Considerations for Stem Cell Therapies
CIRM will host this webinar as the sponsor of the Regenerative Medicine Consortium’s (RMC’s) webinar series on IND readiness. The mission of the RMC is to accelerate the development and regulatory approval of stem cell and regenerative medicine therapies. Free webinar. Detailed Information

September 28: Bio2Device Group | Revamping Risk Management – A Renewed Imperative
The bar for risk management has suddenly moved higher for medical device companies. After numerous product-safety-related recalls and field actions over the past few years, the Food and Drug Administration (FDA) has dramatically increased its scrutiny of product risk management practices, demanding adherence to the current standard, ISO 14971:2010. With the agency now examining risks in terms of the worst possible outcome, practices that had been presumed acceptable are subject to heightened scrutiny. This session will cover some of the changes in thinking at FDA, and how firms and individual contributors can and ought think about risk management in the new environment. We will offer a perspective on the what, who, how, when and where of risk management throughout the product life cycle. In Sunnyvale. Detailed Information

September 30: CEO Roundtable Discussion
This CEO panel discussion will have representatives from the local small, mid size, and large Pharma/Biotech sector located within the Bay area. Majority of the panel is female, but will also include male leadership. Discussions would focus around current challenges and the uncertain market place.

September 30: CEO & CFO Roundtable | Prescription for Success: Managing Your Executive Team
In an ideal world, you pick your own executive team and it is productive, delivers high performance, fosters innovation and, most importantly, helps you to manage complex issues. Reality, of course, is different with a CEO frequently inheriting a team assembled by someone else with both high-performers as well as slightly less than high achievers abound. How do you play to the natural strengths of your executive team that lead to peak performance? How do you best manage your executive team dynamics? What are the best communication tools and techniques? How do you manage a conflict? At what point do you bring an executive coach? How and when do you make a decision to replace your senior executives? And, finally, how do you know that you are the most effective manager yourself? Join CEOs from leading life sciences companies for an interactive session, to hear their war stories, to discuss real life solutions and learn of the practices that produce best results. In Redwood City. Detailed Information.

October 1: Bioscience Leadership 2020
What will it be? What will it require? How will it differ from bioscience leadership today? For thought-provoking commentary on these topics and more, join Keck Graduate Institute. George Savage MD, Co-Founder and Chief Medical Officer, Proteus Biomedical, (www.proteusbiomedical.com) discusses the leadership imperative for our industry over the next decade. Details to follow.

October 1: Applying the Principles of Project Management in Clinical Development
Biopharmaceutical professionals learn to use the tools and techniques of project management as they apply to industry-specific needs in clinical development. Detailed Information

October 1: IND/CTA Preparation and Submission
Master the role of regulatory affairs in the preparation, development, submission, and approval of the IND/CTA, including the roles of project management professionals. Using case studies, examine the various components of the submission, how it is prepared using subject matter experts, how its accuracy can be assured, how it is submitted, how to respond to
regulatory inquiries, and the process for initiating trials. Detailed Information

October 2: Principles of Regulatory Affairs
Get an introduction to the regulatory authorities, whose regulations and requirements must be implemented and met to ensure compliance to the laws governing this industry. Learn the steps leading to testing products in humans, the approval of products and post-approval requirements, and industry implementation. Detailed Information

October 2: Molecular Pharmacology
Molecular pharmacology is the study of drugs and how they interact with the cell at a molecular level. Designed for professionals working in pharmaceutical or biotechnology fields, this course examines advances in molecular pharmacology that have changed our understanding of the ways in which drugs act. The instructors discuss the interaction between drug or neurotransmitter and receptor, the interaction between receptor and cell, and the relationship between receptors and drug design. In addition to the role of recombinant DNA technology and its use within the field, plan to study recent research on the structure and function of receptors and the application of this research to the design of novel therapeutics. Detailed Information

October 2: Overview of the Medical Device Industry
The medical device industry is one of the fastest-growing high-technology sectors in the United States and in the world. There are currently over 8,000 types of medical device products, and the industry promises even further growth. Scientific advances in medicine, the demographics of an aging population, the integration of drugs and biologics into devices, and the
increase in consumer-directed self-care are powering this growth. Gain perspective on the current state of the medical device industry, including local and global opportunities and challenges. Detailed Information

October 4: Current Topics in the Biosciences
Study current topics in the biosciences including the areas of cell biology, molecular biology, neurobiology, genetics, developmental biology and virology, immunology, and infectious disease. Learn to prepare and deliver a scientific presentation. This course is intended for advanced science students with some previous knowledge of cell biology, molecular biology, and genetics; industry professionals and health professions students can also benefit from this course. Detailed Information

October 4: The Drug Development Process
Get a detailed picture of all aspects of the complex and highly interrelated activities involved in bringing a pharmaceutical discovery to approval and market. The focus is on drugs (small molecules); however, course discussions integrate biologics, diagnostics, and devices. Provided by 10 industry experts, this course is designed for executives, disciplinary experts, entry-level employees, investors, and others interested in a full understanding of the biopharmaceutical industry. Topics include industry environment, discovery and pharmacology, chemistry manufacturing and controls, toxicology, pharmacokinetics, program management, FDA inspections, biologics, assays and devices, clinical trial design and conduct, clinical trial statistics, pharmacogenomics, FDA compliance regulations, patents and intellectual property, and commercial development. Case studies are presented for group discussion. Breakfast, refreshments, lunch, and social hours are included. Enrollment is limited to 45 to support a high degree of interaction between attendees and speakers. Detailed Information

October 5: Bio2Device Group | RoadMAP to Leadership – How to Develop and Train in a Small Biotech Environment
How do small to medium sized /biotech/med-device companies infuse learning and development programs for key managers/directors and influence the executive team to fund this new program in light of cost constraints and budget cuts. How can HR make it happen and the by-product culminating in the Executive Team wanting to desperately join and be a “willing and instructional participant?” In Sunnyvale. Detailed Information

October 5: New Obama Healthcare Law Federal and State Reporting Requirements and Aggregate Spend Forum
Seth Lundy, Partner from King & Spalding's Washington, DC office and Andy Bender, President of Polaris from New York City will be speaking at this free conference that will cover the new nationwide financial reporting requirements that impacts tracking and reporting spending on healthcare professionals, doctors, consultants and clinical trials. The program will be held at the San Francisco Airport Westin, one Bayshore Highway, from 8:30 am-3:30pm. To RSVP before September 24th or for more information, please contact Anne Sheals at 202-661-7946 or asheals@kslaw.com.

October 5-6: BIO Investor Forum
This national investor forum delivers a rich program that includes 140 corporate presentations and one-on-one meetings between investors, analysts, and participating companies. Hosted by the Biotechnology Industry Organization, BIO Investor Forum explores investment trends and opportunities in life sciences and focuses on public and venture-stage growth companies. Showcase your company story in presentations to qualified investors at this leading West Coast investor event. Network with peers, investors and potential partners in informal settings and private one-on-one meetings. Get the pulse on the latest life sciences investment trends from sophisticated investment and company executives. Hear from and meet with executives at the top life sciences growth companies. Benefit from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice. Get a ‘big picture’ overview of the industry and the issues affecting product innovation, capitalization, and commercialization. BayBio members qualified as discovery-track biotech companies receive discounted registration and company presentation rates. To receive this discount, register at BIO member rates and indicate that you are a BayBio member (membership is subject to verification). At the Palace Hotel, San Francisco, CA. Detailed Information

October 6, 2010: BayBio Summer Blowout Mixer and Open House
Join BayBio for its End of Summer Blowout Mixer at the Pacific Research Center, immediately off of Highway 84 and the Dumbarton Bridge in Newark. Barbecue and ice cream set the stage for this entertaining networking reception. Meet BayBio staff and vendors to learn more about cost-saving tips and BayBio Business Solutions. Leave with detailed insight into how BayBio can help your organization succeed and lower its bottom line using BayBio Business Solutions. The Pacific Research Center is a 10-building multi-tenant campus with 1.4 million square feet of laboratory, R&D and office space. Tours of the campus and laboratory suites at the Pacific Research Center will be offered by its owner, BioMed Realty Trust. Detailed Information

October 6: Introduction to Nanotechnology in Medicine
Learn the basic concepts and principles of nanotechnology. Because of its significance and potential impact, you focus on nanotechnology's many uses in medicine, with a particular emphasis on cancer therapy. Study examples of ongoing applications of nanotechnology in disease diagnosis and treatment. Detailed Information

October 7: Chuan Gao and Ted Apple, Townsend and Townsend and Crew
The QB3 Entrepreneurs’ Discussion (QED@QB3) series seeks to inspire, connect, and educate entrepreneurs. The backbone of the program consists of luncheon seminars by leading entrepreneurs, venture capitalists, and industry experts on technical matters necessary to launch a successful bioscience startup. These seminars also provide a great venue for members of the QB3 Garage Network and wider biotech community to meet with entrepreneurial students, staff, and faculty. We also hold special seminars at other times. In San Francisco. Detailed Information

October 7-8: Bioscience Business and Marketing Essentials
The bioscience industry is like no other. Lengthy timelines and unique financial, legal, regulatory, social and political challenges impose constraints that impact every aspect of the business. This course helps participants gain: a practical understanding of the bioscience industry landscape, key business drivers and challenges; insight into the critical roles that business and marketing disciplines play at all stages of a bioscience company's development; and hands-on experience implementing important bioscience business processes that are essential to success within the industry. Two days of intensive classroom are followed by 2 months to complete individual project with guidance of instruction and access to research resources. In Santa Clara. Detailed Information

October 7-8: BioExec Institute 2010 | Module A - Creating Value
The BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from October through December 2010, including three evening networking receptions. Participants will have unique opportunities to debate the strategies and tactics of business leadership within biopharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry. At the end of the program, participants will be awarded a certificate of completion by the UC Berkeley Center for Executive Education. BayBio discount code for bioexec is prbpr10 ($500 off). In Berkeley. Detailed Information

October 9: Entrepreneurship in the Life Sciences Industries
Get an introduction to the complexities and unique problems of starting a life sciences company, particularly if you are an entrepreneur, investor, or government official who may work in or work with biotechnology, pharmaceuticals, or related disciplines. Gain exposure to the topics most critical for successfully founding, financing, and operating a life science company, and perform many of the same tasks that founders would normally undertake. Detailed Information

October 9: Venture Funding and Due Diligence: Financing a Biotechnology Company
Focus on the financing how-tos for venture-funded start-up companies in the life sciences sector. Study contemporary start-up topics covering the history, culture, and evolution of biotech businesses and business models. You are introduced to the basics of starting a biotechnology or life science company from the perspective of a first-time entrepreneur. Creating
a business, finding funding, and passing investor due diligence are covered in detail with many examples of successful biotech business models and funding sources. Detailed Information

October 9: Preparing for Commercialization
The role of product and process development is integral in preparing for licensure of a biopharmaceutical product. Become a procedural subject matter expert, and learn to write the CMC section of the NDA/BLA/MAA. Define process, development, product characterization, testing, and stability. Gain up-to-date information on regulatory agencies' current policies, and critically understand how to apply them. Detailed Information

October 9: Principles of Manufacturing and Supply Chain
Study the principles of supply chain and the supply of materials for clinical trials and commercial sales. Master the regulations that must be followed, and understand how to implement them in operations to ensure compliance with the laws governing the biopharmaceutical industry. Detailed Information

October 9-14: DMA2010 Conference & Exhibition
DMA2010 is the Global ROI Marketing Event, focusing on direct and digital marketing integration across all channels! Learn from 300+ experts from Pepsi, LG, HP, Twitter, and more, on how to do it right and maximize ROI! Register one, and get the second FREE! Register with Keycode SMBO. In San Francisco. Detailed Information

October 10 - 12 | BioPartnering Europe
BioPartnering Europe™ (BPE) is Europe`s longest-running life science partnering event and is a "must attend" event for decision-makers across the globe. BPE facilitates partnering, business development, investment efforts and face-to-face meetings supported by the biopartnering.com online network. BPE annually attracts 1,200 delegates from over 30 countries. BPE is Europe's most productive partnering meeting where you can find the right partners to grow your pipeline. Global pharma partners are competing for prize biotech assets and at BPE 2010 you have the opportunity to connect with the partners you need. Join us at BPE 2010 and hear from over 100 podium presenters and biotech companies looking for partnerships and investors to sustain their growth in 2011. BayBio life science company members receive 15% discount off registration by using discount code BayBio2010 and a special BayBio Member Registration Link. BayBio life science company members also receive 10% off podium presentation fees - please include "BayBio Member" in the "More Detail" section. Detailed Information

October 14: The Experimental Man
Join David Ewing Duncan as he gives a fascinating talk on his journey to "physical self-discovery" to see what effects medical technologies will have on individuals, families, and cultures. In Berkeley. Detailed Information

October 16: Drugs and Disease: Pharmacogenetics, Pharmacokinetics, and Pharmacodynamics
Get an introduction to the basic principles of pharmacogenetics, pharmacokinetics, and pharmacodynamics. Gain a basic understanding of how the body and drugs interact, including how genetic variation gives rise to different responses to drugs. Topics include drug ADMET, methods for quantitative analysis, and study designs. Discussions have an industrial as well as academic focus. This course benefits students and professionals in the biotechnology and pharmaceutical industries, health care and allied medical fields, academia, and other fields requiring a broad understanding of drugs, genetics, and their possible interactions. Detailed Information

October 16: Inspections and Audits for Quality and Compliance
Gain an understanding of the role quality assurance has when interfacing with governmental regulatory bodies in day-to-day operations. You study the various regulatory elements and expectations—including audits, inspections, recalls, and alerts—and learn how to implement them. Detailed Information

October 16: Post-Baccalaureate Health Professions Program Information Session
Find out about this specially designed program that provides academic preparation in the sciences and advising to enhance your application for admission to medical, dental, or veterinary school, or to advanced degree programs in the health professions. For more information about the Health Professions program, visit extension.berkeley.edu/spos/premed.html. Detailed Information

October 18: FountainBlue | Software Meets Healthcare
This month we examine the convergence of technology and health care, and profile software solutions which benefit health service professionals, from health IT platforms to pharmaceutical tracking, health monitoring and more. In Foster City. Detailed Information

October 20-22 | 6th Modern Drug Discovery & Development Summit
Join your colleagues in an opportunity to network with over 125 leading industrial and academic experts at this three-day summit. The 6th Modern Drug Discovery and Development Summit in San Francisco, CA, on October 20th-22nd, 2010 will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. Featuring keynote plenary sessions with leaders from Roche, Theravance, Human Genome Sciences, and Novartis, this summit will have over 100 distinguished presenters and include four distinct tracks: the 4th Biomarkers Discovery and Development, 2nd Cancer Targets and Therapeutics, 4th Advances in Stem Cell Discovery and Development, and 5th Biological Therapeutics. Save up to $350 per registration: BayBio members receive 20% discount when registered by September 1 or 10% by October 1. Detailed Information & Registration

October 21, 2010: BayBio Life Science Series Therapeutic Focus | Drug and Biomarker Developments: The Evolution of Blockbusters?
The promise of personalized medicine has begun to be realized with several commercially successful products, notably Herceptin, Gleevec, and Rituxan that all rival conventional "blockbusters." Higher rates of efficacy and more efficient (and therefore cost effective) trials have made products based on biomarkers increasingly intriguing and attractive to an industry chronically beset with R&D failures. Should we expect life science and pharma companies to embrace the biomarker strategy as their primary business model, or will biomarker-derived products remain a niche market? And should diagnostics be developed in tandem with pharmaceuticals or independently? A panel of experienced industry executives will focus on the real world experiences and will provide valuable insight into business and regulatory landscape surrounding biomarker technology. In South San Francisco. Detailed Information

October 21: Navigating a Career Transition into the Life Sciences
Identify a career path in the life sciences and biotechnology sectors that best suits your interests, skill sets, and career goals. Through lectures, a self-assessment test, and discussion, you can develop an understanding of a variety of career paths in the life sciences, including sales and marketing, business development, clinical and regulatory affairs, project management, and discovery research. Get practical job search advice, as well, on topics such as working with recruiters, résumé building, networking, and interviewing. Detailed Information

October 22: Opportunities and Challenges in Managing Global Projects
Biopharmaceutical professionals acquire the necessary project management tools and techniques to manage global projects. Learn how to manage resources across borders to take advantage of the growing opportunities and challenges of clinical trials in Europe, Asia, and Latin America. Learn through lectures, case studies, problem sets, class discussion, and student projects. Detailed Information

October 23: Initiating a Start-Up Company in the Life Sciences Industries
Get an introduction to the basic operational requirements for initiating a start-up company in the biotechnology or specialty pharmaceutical space. Both the budding entrepreneur as well as research personnel contemplating joining a start-up venture are introduced to the necessary steps for developing an entrepreneurial idea into a funded and viable small company. Requirements are discussed in detail for the following stages of development: patenting the technology, in-licensing technology, creating term sheets, and meeting with and securing venture capital or other types of funding. Detailed Information

October 24-27: 2010 RAPS Annual Conference & Exhibition
As the changing regulatory landscape increasingly requires you to work across international lines, you must master new areas of knowledge, including worldwide regulations, how to deal with different global agencies, business strategy, management, technology and much more. Learn how to position yourself and your company for success in the global regulatory landscape by attending the 2010 RAPS Annual Conference & Exhibition. An expanded global perspective, groundbreaking regulatory insight from renowned experts around the world and invaluable networking opportunities make this the one meeting you can't afford to miss—no matter what your level of experience or product specialization. In San Jose. Detailed Information

October 25: Bioscience Essentials for Industry Professionals
This intensive course provides a focused introduction to the fundamental concepts and principles of biology, presented in the context of their relevance and application to the bioscience industry. Students develop the basic conceptual framework and vocabulary necessary to communicate effectively with technical specialists within their companies and to comprehend
the basic scientific concepts in proposals, prospectuses, and market and technical assessment reports. Additionally, you explore current techniques and technologies while developing an appreciation of the process and the challenge of turning scientific discoveries into successful products. Detailed Information

October 25: UCSF | American Course on Drug Development and Regulatory Sciences (ACDRS)
The ACDRS supports the FDA’s Critical Path Initiative to modernize the science required to deliver medical products to market. The ACDRS is an educational course established in 2006 by the School of Pharmacy, University of California San Francisco, working with the FDA, a network of universities, biopharmaceutical companies and the European Center for Pharmaceutical Medicine in Basel, Switzerland. The teaching faculty is comprised of recognized international experts in regulatory sciences, medical product discovery and development, product evaluation and business practices from US and European biopharmaceutical companies and regulatory authorities. Participants will integrate workplace goals with the education needed to better accomplish those goals, through actively engaging in lectures, workshops, panel discussions and team-oriented case studies. In San Francisco. Detailed Information

October 26: Biotech Supply Chain
The world's leading community for biotechnology supply chain professionals will be meeting at the Embassy Suites in South San Francisco on October 26, 2010, for the 3rd annual Biotech Supply Chain Academy conference. The expanded multi-track conference titled "Transforming the Global Supply Chain for End-to-End Visibility and Quality Patient Care" will be identifying and developing supply chain solutions for the industry's expanding world presence with a clear focus on patient care. The Call for Papers requests expert speakers to present on topics enumerated below and others deemed pertinent and valuable. In South San Francisco. Detailed Information

October 27: Junior Diabetes Research Foundation Annual Silicon Valley Summit
The second year of this summit will be held in Menlo Park. More information to follow.

October 27, 2010: JDRF Annual Silicon Valley Summit | Discovery to Development: Pathways for Advancing and Financing New Therapies
Please “Save the Date” for this ground-breaking summit featuring four perspectives on translational medicine, innovation and industry brought to you by the Juvenile Diabetes Research Foundation (JDRF) in association with the Stanford School of Medicine. Panelists include: Karin Hehenberger, M.D., Ph.D., Senior Vice President, Strategic Alliances for the Juvenile Diabetes Research Foundation; Daria Mochly-Rosen, Ph.D., Senior Associate Dean for Research & the George D. Smith Professor in Translational Medicine, Stanford University; Beth Seidenberg M.D., Partner, Kleiner Perkins Caufield & Byers; PJ Utz, M.D., Co-Founder and Consultant, Bayhill Therapeutics. In Menlo Park. Detailed Information

October 27: Clinical Trial: Data Analysis, Regulatory Audits, Vendor Selection, and Project Management
Learn the clinical study report and other procedures at study close-out to prepare yourself for regulatory audits and inspections. Get an overview of project management and vendor selection in clinical research. Detailed Information

November 1-2, GGPF short course "Crystallization and Mechanical Behavior of Polymers"
The Golden Gate Polymer Forum is sponsoring a 2-day short course covering crystallization and mechanical behavior of polymers and taught by a well-known instructor, Pravin Soni. The objective of this course is to provide a detailed introduction to structure-processing-property relationships in polymers, with an in-depth review of crystallization and mechanical properties. Attendees will learn about important aspects of crystallization and mechanical properties of polymers and how they relate to conventional polymer processing, with emphasis on practical applications. The concepts covered in this seminar will serve as valuable tools for material selection and process optimization, and will help polymer users to predict material performance. Pravin Soni has a BS in Chemical Engineering and a Ph.D. in Polymer Science from Case Western Reserve University. His research and development interests include structure-processing-property relationships, crosslinking, crystallization, and mechanical and electrical behavior of filled and unfilled polymer systems, medical applications of polymers, and development of medical devices and drug delivery systems. He has co-authored nineteen (19) papers and fifty seven (57) patents on these subjects, and has taught courses in polymer physics at Society of Plastics Engineers' meetings. Dr. Soni is Founder and President of Pharmacro, LLC, providing consulting services for the development of medical devices, drug delivery systems and combination medical products. Detailed Information

November 2: Effective Presentation Skills for Scientists
Focus on the skills needed to prepare and deliver a high-impact scientific presentation. Working professionals and students in professional or graduate science programs learn how to effectively prepare and comfortably deliver scientific presentations of various formats, including short research talks, research seminars, formal conference presentations, informal lab group meetings, and job talks. In addition, you learn how to deliver constructive criticism. Detailed Information

November 4: Dan Burnett
The QB3 Entrepreneurs’ Discussion (QED@QB3) series seeks to inspire, connect, and educate entrepreneurs. The backbone of the program consists of luncheon seminars by leading entrepreneurs, venture capitalists, and industry experts on technical matters necessary to launch a successful bioscience startup. These seminars also provide a great venue for members of the QB3 Garage Network and wider biotech community to meet with entrepreneurial students, staff, and faculty. We also hold special seminars at other times. In San Francisco. Detailed Information

November 4: BayBio Pantheon 2010 | Presenting DiNA Awards
Each year BayBio recognizes achievement and honors excellence in the life sciences industry in Northern California, as it brings together Northern California’s life sciences industry leaders. The Pantheon Awards Ceremony is a celebration of the contributions and achievements of the Bay Area, a moment in time to pause and reflect on the industry's legacy over three decades. In San Francisco. Detailed Information

November 4-5: BioExec Institute 2010 | Module B - Managing Value
The BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from October through December 2010, including three evening networking receptions. Participants will have unique opportunities to debate the strategies and tactics of business leadership within biopharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry. At the end of the program, participants will be awarded a certificate of completion by the UC Berkeley Center for Executive Education. BayBio discount code for bioexec is prbpr10 ($500 off). In Berkeley. Detailed Information

November 4-5, 2010: BioBasics- 2 Day Class | Industry Knowledge for the Non-Scientist
Learn the basics of biotechnology by skilled and experienced industry scientists. Join other non-science professionals and gain a thorough understanding of the science, technology and terminology which form the foundation of the biotechnology industry. Click here for the class agenda. Detailed Information

November 5: Alliance Management in the Biopharmaceutical Industry
Learn the necessary project management tools, techniques, and trends in managing alliances with partners, vendors, and contractors. Detailed Information

November 5: Post-Approval Activities
Understand the role of regulatory affairs after licensure and commercialization of a biopharmaceutical product, including responsibilities and relationships with other functions. Using case studies, examine Phase 4 studies, safety surveillance, label management, sNDA, sBLA preparation and submissions, prior approval supplements, CBE-30 and annual reportable supplements, field alerts, and recalls. Detailed Information

November 7: Health Careers Seminar II
This second of a two-course required sequence prepares you for the comprehensive application process to health career professional programs. You review healthcare professional programs and further clarify your interest in healthcare careers, admission requirements, length of study, and workforce issues. You plan your approach for the written application form. You learn to write personal statements and practice interview questions. You also learn strategies to finance your healthcare education. Your classroom experience includes lectures, in-class interactive presentations, case studies, and opportunities for private and semi-private meetings with the instructors. Detailed Information

November 9: Professional Biomedical Sciences Program
With the Professional Biomedical Sciences Program, you can fill in knowledge gaps from previous academic training, learn about current topics and techniques, and participate in a flexible and up-to-date professional development program that prepares you for career advancement within the biosciences. Come to a free, no-obligation event to learn how you can benefit from this new Extension program. Detailed Information

November 9: NCI Investor Forum
The NCI SBIR will host its second annual exclusive event designed to connect the strongest and most promising NCI SBIR companies with life science investors and strategic partners. This is a rare occasion for attendees to get a first look at some of the best early-stage oncology companies currently funded by the NCI, and to establish new collaborations. * Presentations by emerging companies with innovative cancer-related technologies on the brink of commercialization. All companies presenting will be pre-screened by an independent panel of experts from venture capital firms, bio-pharmaceutical, and medical device companies. * Private breakout sessions with featured companies to further discuss prospective collaborations. * Meetings with NCI SBIR Development Center leadership to learn about the NCI SBIR Bridge Award, a unique $3 million funding opportunity to accelerate promising cancer-related technologies to commercialization. * Keynote presentation, "Emerging In Vitro and In Vivo Diagnostic Technologies," by Sanjiv Sam Gambhir, M.D., Ph.D., Director, Molecular Imaging Program at Stanford. * Private breakout sessions with the NCI SBIR Development Center staff to discuss funding available through the NCI SBIR program. * Networking reception with other leaders in the life sciences and medical technology industry. In Palo Alto. Detailed Information

November 9-10: Advanced Biofuels Markets
The Obama Administration has projected that the US alone will need to construct 500 advanced bioenergy plants between 2011 and 2022 to comply with the Renewable Fuel Standard of 21 billion gallons per year of Advanced Biofuels by 2022. 21 billion gallons starts with the first billion - the first commercial-scale plants that will carve out the business models and demonstrate the sustainability and viability of the technologies. The Advanced Biofuels Markets conference will bring together leading experts who are bringing advanced biofuels to market, including Advanced Biofuels Company Executives, Venture Capitalists and Investment Bankers, Corporate Strategic Investment and Alliance Executives, EPC firms and industry suppliers. In San Francisco. Detailed Information

November 13: Biopharmaceutical Product and Process Development
Regulations, requirements, and guidelines govern certain parts of the development of products and processes and the eventual manufacture and distribution. Develop knowledge of the procedures at every stage of the process. Attend a free, no-obligation event where Extension staff will outline a clear educational path for you to achieve your biopharmaceutical career goals. Detailed Information

November 13: Bioscience Manufacturing and Supply Chain
Get the training you need to perform and oversee supply chain and manufacturing functions within the biopharmaceutical industry. Attend a free, no-obligation evening to learn from Extension staff about how our courses can benefit your personal and career goals. Detailed Information

November 13: Professional Program in Biopharmaceutical Business
The Professional Program in Biopharmaceutical Business features a comprehensive curriculum that encompasses the specific business needs of the biopharmaceutical industries. Electives draw from other areas within this industry to ensure that professionals from all backgrounds can communicate easily and understand the roles of various functions within disparate business units. Detailed Information

November 13: BLA/NDA/MAA Submissions and Commercialization
Understand the role of regulatory affairs in the course of clinical trials. In addition to learning roles and responsibilities, study how they interface between the professional and other departments and the regulatory bodies. Using case studies, master the various components and processes to enable a successful licensure of a biotechnology product. Detailed Information

November 13: Principles of Product and Process Development
Gain an overview of product and process development in a biopharmaceutical setting. Learn the steps and requirements for developing products and processes for eventual use in clinical trials and introduction into commercial plants. Understand the various elements and expectations of the regulations and how they must be implemented in a stepwise fashion. Gain up-to-date information on regulatory agencies' current expectations, and critically understand the regulations' requirements and how to apply them in principle. Detailed Information

November 14 – 17: The Behavior, Energy and Climate Change (BECC) Conference
Attend the preeminent conference focused on the practical applications of social and behavioral research to achieve viable solutions to energy/climate challenges that increase America's energy independence and national security and create sustainable jobs. It builds on the overwhelming success of previous BECC conferences at which 700 participants from universities, government, corporations and media discussed successful policy and program strategies, shared important research findings, and created dynamic new networks and collaborations. In Sacramento. Detailed Information

November 15: FountainBlue | Personalized Medicine, Biomarkers, Invitro Diagnostics: The Science Advances, The Business Opportunities, The Cultural Dilemmas
The accelerated pace of technology advancements is opening up new offerings in personalized medicine, in biomarker training, in Invitro diagnostics. This month we feature roundbreaking leaders to showcase advances and opportunities in this market and touch upon cultural and moral dilemmas which arise as these offerings gain traction. Detailed Information

November 16: Green Chemistry
Green chemistry, the study of matter and how it changes, can greatly influence human health and the health of the environment. Find out how green chemistry can unleash your creativity in designing and discovering the next generation of chemicals and materials. Detailed Information

November 18: 2nd Annual Life Sciences Finance and Accounting Forum
For over six years, the Pharmaceutical/Biotech Financial Series Events have covered the most current finance/accounting hot topics, convening influential speakers and over 3,000 attendees to date. Mark your calendar for this focused and comprehensive one-day Forum, which delves into key accounting and biotech financial reporting issues, as well as strategies in corporate financing and business development. A ‘best-in-class’ reputation, CPE credits and professional networking make this a very worthwhile event! Detailed Information

November 19: Applying the Principles of Project Management in Life-Cycle Management for Biopharmaceuticals
Biopharmaceutical professionals learn to use the tools and techniques of project management as they apply to industry-specific needs in life-cycle management. The course covers scope management, time management, successful commercialization, cost, procurement, and risk management. Learn through lectures, case studies, problem sets, and class discussion. Detailed Information

November 30: Post-Baccalaureate Health Professions Program Information Session
Find out about this specially designed program that provides academic preparation in the sciences and advising to enhance your application for admission to medical, dental, or veterinary school, or to advanced degree programs in the health professions. For more information about the Health Professions program, visit extension.berkeley.edu/spos/premed.html. Detailed Information

December 2: SBIR Grants
The QB3 Entrepreneurs’ Discussion (QED@QB3) series seeks to inspire, connect, and educate entrepreneurs. The backbone of the program consists of luncheon seminars by leading entrepreneurs, venture capitalists, and industry experts on technical matters necessary to launch a successful bioscience startup. These seminars also provide a great venue for members of the QB3 Garage Network and wider biotech community to meet with entrepreneurial students, staff, and faculty. We also hold special seminars at other times. In San Francisco. Detailed Information

December 4: Best Practices Approaches in Project Management for Biopharmaceuticals, Medical Devices, and Vaccines
This course introduces biopharmaceutical professionals to the current best practices of project management in the areas of biopharmaceuticals, medical devices, vaccines, and blood testing. Learn through lectures, case studies, problem sets, class discussion, and student projects. Detailed Information

December 4: Developing Processes
Gain an understanding of the process-development life cycle from concept to commercialization. Studying process development at the various stages of product development and at various scales, you learn to link this activity to the product's development from initial concept to marketable product. Detailed Information

December 4: Manufacturing Operations
Study the role of supply chain and manufacturing professionals in plants that manufacture clinical and commercial materials. Master the various elements and expectations of industry regulations and how they must be implemented. Detailed Information

December 4: Certificate Program in Clinical Research Conduct and Management Information Session
Learn how this program can help you launch or advance your career in clinical research by enhancing your knowledge of clinical trials. For more information about the program, visit extension.berkeley.edu/cert/clinical.html. Detailed Information

December 4: Professional Program in Project Management for Biopharmaceuticals Information Session
Find out how this program provides the specific knowledge experienced project managers need to succeed in the pharmaceutical, biotechnology, medical device, and diagnostics industries. For more information about this program, visit extension.berkeley.edu/spos/biopharmpm.html. Detailed Information

December 4: Professional Program in Quality and Compliance for Biotechnology Information Session
This professional program focuses on the area of quality assurance, quality control and regulatory compliance. These disciplines are critical in the growing and increasingly regulated biotechnology industry as it is the first-line assurance that your operations are in compliance with the extensive and ever-changing regulations imposed in the United States and worldwide. You meet instructors and staff who can answer your questions about how this program can help you meet the challenges in your biotech career. Detailed Information

December 4: Regulatory Affairs Information Session
Discover how UC Berkeley Extension's regulatory affairs courses can help advance your training, whether you want to enter the biopharmaceutical industry or seek to manage regulatory affairs within your own company. Detailed Information

December 7: Post-Baccalaureate Health Professions Program Information Session
Find out about this specially designed program that provides academic preparation in the sciences and advising to enhance your application for admission to medical, dental, or veterinary school, or to advanced degree programs in the health professions. For more information about the Health Professions program, visit extension.berkeley.edu/spos/premed.html. Detailed Information

December 11: Post-Baccalaureate Health Professions Program Information Session
Find out about this specially designed program that provides academic preparation in the sciences and advising to enhance your application for admission to medical, dental, or veterinary school, or to advanced degree programs in the health professions. For more information about the Health Professions program, visit extension.berkeley.edu/spos/premed.html. Detailed Information

December 7-8: BioExec Institute 2010 | Module C - Growing Value
The BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming from October through December 2010, including three evening networking receptions. Participants will have unique opportunities to debate the strategies and tactics of business leadership within biopharma and will complete the program with invaluable insight and powerful networks to help them deliver bottom-line value in this growing industry. At the end of the program, participants will be awarded a certificate of completion by the UC Berkeley Center for Executive Education. BayBio discount code for bioexec is prbpr10 ($500 off). In Berkeley. Detailed Information

December 9: San Jose BioCenter | 6th Annual Trends in Financing Investor Panel & Holiday Celebration
Steady capital is a must for all companies. The first step in funding is knowing where to look. Join experts from the investment world at our annual “Trends in Financing Investor Panel & Holiday Celebration” to understand the types of financing that are occurring in your industry today - including topics such as who is getting funding while the world faces complex financial challenges - and what is new and to expect for 2011. In Menlo Park. Detailed Information

2011 Events

January 10-12: Biotech Showcase 2011
Biotech Showcase™ provides private and public life science companies the opportunity to present to an audience of investors and business development executives during the course of the largest annual healthcare investor conference. In its third year, Biotech Showcase moves to Parc 55 Wyndham San Francisco – Union Square and will expand to three full days. The program will include lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies. In San Francisco. Detailed Information

January 27, 2011: BayBio Life Science Series VC Spotlight | Changing Biotech Business Models
A wave of generic drugs based on today’s top blockbusters, the expansion of personalized medicine, fundamental healthcare reform in the United States, and the continued globalization of the industry – on top of a global financial crisis – have made the standard biotech business model unsustainable. How can the industry change the ways in which drugs are developed and commercialized? What are the alternative business models? What is the goal (fail early and cheap)? And are investors driving change in behavior? A panel of seasoned investors – VCs, angels, and corporate investors – will reflect on investments made over the last two years and during the 2011 JP Morgan Healthcare Conference, highlighting what life science entrepreneurs should expect ahead. Q&A and networking will provide an opportunity to better understand and form a successful relationship with investors. In South San Francisco. Detailed Information

April 21-22, 2011: BayBio2011 Annual Conference | Powering Global Innovation
With Northern California regarded as a global innovation engine, the BayBio2011 Annual Conference will explore themes and topics that focus on fostering global collaborations in research, development and commercialization. The BayBio2011 Annual Conference is expanding into a two-day event and will attract more than 1,000 life science professionals from around the globe. In Burlingame. Detailed Information

If you would like to have your event listed on the BayBio community calendar, send us an e-mail: info@baybio.org. Please make sure to include date, name and location of your event, a short description and a dedicated link. BayBio Community Calendar is updated every Tuesday. All postings are subject to BayBio approval.